A Clinical Observation of 1064-nm Q-Switched Fractional Laser Combined With Oral Tranexamic Acid on Treating of Melasma.

NACompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

May 1, 2019

Primary Completion Date

February 1, 2020

Study Completion Date

May 1, 2020

Conditions
Melasma
Interventions
DRUG

tranexamic acid

Oral tranexamic acid group(menstrual period\>2days) 250mg bid(exclude menstrual period )

RADIATION

1064-nm Q-Switched fractional laser

Device: 1064-nm Q-Switched fractional laser is used for melisma with the MASI ≥24 left side of cheek is selected to be treated with 1064-nm Q-Switched fractional laser therapy (8ms, 1.5±0.5J/cm2) once 4 weeks for a total of 5 times

RADIATION

1064-nm Q-Switched laser

Device: 1064-nm Q-Switched laser is used for melisma with the MASI ≥24 right side of cheek is selected to be treated with 1064-nm Q-Switched laser therapy (8ms, 1.5±0.5J/cm2) once 4 weeks for a total of 5 times

Trial Locations (1)

710032

Dermatology Derpartment of Xijing Hospital, Xi'an

All Listed Sponsors
collaborator

Air Force General Hospital of the PLA

OTHER_GOV

collaborator

First Hospital of China Medical University

OTHER

collaborator

Chinese Academy of Medical Sciences

OTHER

lead

xjpfW

OTHER

NCT03963466 - A Clinical Observation of 1064-nm Q-Switched Fractional Laser Combined With Oral Tranexamic Acid on Treating of Melasma. | Biotech Hunter | Biotech Hunter